Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/216572
Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Hepatitis D virus (HDV) infection is a global public health concern, especially because of its unique existence in the presence of hepatitis B virus infection. HDV infection is estimated to affect 12 million people globally. Having a clearer understanding of its prevalence in all regions of the world is essential for helping direct preventive and early interventional treatment. This mini-review assessed the literature over the last 10 years to determine the prevalence, diagnostic means and treatment guidelines available for HDV in the Middle East. The search found limited data available in 21 articles, of which 18 were studies focused on Iran. Prevalence rates ranged dramatically among the countries, and none of the 12 countries included in the search had specific HDV guidelines. This review highlights the urgent need for more precise data for the Middle East region to help establish early diagnosis and treatment options for HDV.
Subject (English)
Citation
Citation
LAZARUS, Jeffrey V., et al. Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review. Liver International. 2023. Vol. 43, num. 116-123. ISSN 1478-3223. [consulted: 13 of June of 2026]. Available at: https://hdl.handle.net/2445/216572